Because the VHL/HIF/VEGF pathway plays an important role in neovascularization [2, 10, 11], targeting HIFs could be an antineovascularization treatment of AMD and other retinopathies caused by angiogenesis. The gene discussed is VEGFA; the disease is age-related macular degeneration.